Evaluation of enalapril/diltiazem ER in hypertensive patients with coexisting renal dysfunction

Journal of Human Hypertension

Volumn 10, Issue 11, 1996, Pages 769-774

  Hricik, D E ^a   Levine, B S ^b,f   Adrogue, H J ^c   Weinberg, M S ^d   Goldstein, R ^e  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Hypertension and Nephrology Inc   (United States)

^e Building 500 ^*  (United States)

^f Nephrology Section (111L)   (United States)

Author keywords

Enalapril diltiazem ER; Renal dysfunction

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; AGED; ARTICLE; ASTHENIA; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

ADULT; AGED; BLOOD PRESSURE; CREATININE; DELAYED-ACTION PREPARATIONS; DILTIAZEM; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; MIDDLE AGED; PROTEINURIA;

EID: 0030459042     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. National High Blood Pressure Education Program. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Bethesda, MD: U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute, January 1993, NIH publication no. 93-1088.
2. National High Blood Pressure Education Program. National high blood pressure education program working group report on hypertension and chronic renal failure. Arch Intern Med 1991; 151: 1280-1287.
3. Lewis, EJ, Hunsicker LG, Bain RP, Rohde RD for the Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462.
4. Bauer JH, Reams GP. Renal effects of angiotensin converting enzyme inhibitors in hypertension. Am J Med 1986; 81 (Suppl 4C): 19-27.
5. Reams GP, Bauer JH. Effects of calcium antagonists on the hypertensive kidney. Cardiovasc Drugs Ther 1990; 4: 1331-1336.
6. Reams GP. Do calcium channel blockers have renal protective effects? Drugs Aging 1994; 5: 263-287.
7. Reams GP, Bauer JH. Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction. Arch Intern Med 1986; 146: 2145-2148.
8. Sunderrajan S, Reams G, Bauer JH. Renal effects of diltiazem in primary hypertension. Hypertension 1986; 8: 238-242.
9. Materson BJ et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993; 328: 914-921.
10. Applegate W et al. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension. Accepted for publication by Am J Cardiol.
11. Baum T et al. Antihypertensive activity of SCH 31846, a non-sulfhydryl angiotensin-converting enzyme inhibitor. J Cardiovasc Pharmacol 1983; 5: 655-667.
12. Chan PS, Ronsberg MA, Cervoni P. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics. Fed Proc 1984; 43: 1346-1350.
13. Weir MR. Diltiazem: ten years of clinical experience in the treatment of hypertension. J Clin Pharmacol 1995; 35: 220-232.
14. Todd PA, Heel RC. Enalapril - a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 1986; 31: 198-248.
15. Weiner IM. Diuretics and other agents employed in the mobilization of edema fluid. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. Pergamon Press: New York, 1990, pp 708-731.
16. Björck S et al. Renal protective effect of enalapril in diabetic nephropathy. Br Med J 1992; 304: 339-343.
17. Abraham PA, Opsahl JA, Halstenson CE, Keane WF. Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency. Arch Intern Med 1988; 148: 2358-2362.
18. Isshiki T et al. Diltiazem maintains renal vasodilation without hyperflltration in hypertension: studies in essential hypertensive man and the spontaneously hypertensive rat. Cardiovasc Drugs Ther 1987; 1: 359-366.
19. Sunderrajan S, Reams G, Bauer JH. Long-term renal effects of diltiazem in essential hypertension. Am Heart J 1987; 114: 383-388.
20. Samuelsson O. Proteinuria as a prognostic factor during long term hypertensive care. Drugs 1988; 35 (Suppl 5): 48-54.